Association of Cortisol and the Metabolic Syndrome in Korean Men and Women

Overview

Journal J Korean Med Sci

Specialty General Medicine

Date 2011 Jul 9

PMID 21738345

Citations 12

Authors

Sat Byul Park

James A Blumenthal

Soon Young Lee

Anastasia Georgiades

Affiliations

Soon will be listed here.

Abstract

Obesity and the metabolic syndrome are closely related and have become increasingly prevalent in Korea. The cardiovascular disease (CVD) risk factors comprising the metabolic syndrome have previously been associated with increased hypothalamic-pituitary-adrenal axis (HPAA) activity, but the associations have not been extensively examined in non-Caucasian populations. The aim of the present study was to investigate the relationships between cortisol, adiposity and the metabolic syndrome in a Korean population. A total of 1,881 adults participated in the study between January 2001 and February 2008. Sociodemographic data were assessed by questionnaires. Body composition, clinic blood pressures as well as metabolic variables including glucose, insulin, and lipid profile were assessed and analyzed in relation to cortisol levels. Mean age of the participants was 58.7 ± 10.8 yr. Higher levels of cortisol was associated with elevated blood pressure, fasting glucose and total cholesterol in men, and between cortisol and systolic blood pressure, fasting glucose and total cholesterol in women. There was an increased risk for the metabolic syndrome associated with higher cortisol levels in both men (P < 0.001) and women (P = 0.040) adjusting for age and body mass index. Higher cortisol levels are associated with several CVD risk factors and the metabolic syndrome, independent of overall of adiposity level, in Korean men and women.

Citing Articles

Improvement of metabolic syndrome and its components in patients who underwent transsphenoidal resection for pituitary adenoma.

Cortes-Contreras A, Salazar-Pigeon A, Gonzalez-Almazan J, Flores-Rabasa R, Navarro-Olvera J, Mendez-Garcia L Acta Neurochir (Wien). 2024; 166(1):86.

PMID: 38363400 DOI: 10.1007/s00701-024-05938-x.

Association of primary allostatic load mediators and metabolic syndrome (MetS): A systematic review.

Osei F, Block A, Wippert P Front Endocrinol (Lausanne). 2022; 13:946740.

PMID: 36482995 PMC: 9724739. DOI: 10.3389/fendo.2022.946740.

Greenspace, Inflammation, Cardiovascular Health, and Cancer: A Review and Conceptual Framework for Greenspace in Cardio-Oncology Research.

Bikomeye J, Beyer A, Kwarteng J, Beyer K Int J Environ Res Public Health. 2022; 19(4).

PMID: 35206610 PMC: 8872601. DOI: 10.3390/ijerph19042426.

Associations Between and Polymorphisms, and Cardiometabolic Risk Factors in Black South Africans.

Dlamini S, Choudhury A, Ramsay M, Micklesfield L, Norris S, Crowther N Front Genet. 2021; 12:687335.

PMID: 34484290 PMC: 8414563. DOI: 10.3389/fgene.2021.687335.

Glucocorticoids associate with cardiometabolic risk factors in black South Africans.

Dlamini S, Lombard Z, Micklesfield L, Crowther N, Norris S, Snyman T Endocr Connect. 2021; 10(8):873-884.

PMID: 34261039 PMC: 8346194. DOI: 10.1530/EC-21-0195.

References

Rask E, Olsson T, Soderberg S, Andrew R, Livingstone D, Johnson O . Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab. 2001; 86(3):1418-21. DOI: 10.1210/jcem.86.3.7453. View

Grundy S . Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol. 1999; 83(9B):25F-29F. DOI: 10.1016/s0002-9149(99)00211-8. View

McKeigue P, Shah B, Marmot M . Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991; 337(8738):382-6. DOI: 10.1016/0140-6736(91)91164-p. View

Bjorntorp P . Neuroendocrine perturbations as a cause of insulin resistance. Diabetes Metab Res Rev. 2000; 15(6):427-41. DOI: 10.1002/(sici)1520-7560(199911/12)15:6<427::aid-dmrr68>3.0.co;2-c. View

Delaunay F, Khan A, Cintra A, Davani B, Ling Z, Andersson A . Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. J Clin Invest. 1997; 100(8):2094-8. PMC: 508401. DOI: 10.1172/JCI119743. View

Rosmond R, Dallman M, Bjorntorp P . Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab. 1998; 83(6):1853-9. DOI: 10.1210/jcem.83.6.4843. View

Epel E, McEwen B, Seeman T, Matthews K, Castellazzo G, Brownell K . Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. Psychosom Med. 2000; 62(5):623-32. DOI: 10.1097/00006842-200009000-00005. View

Morton N . Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease. Mol Cell Endocrinol. 2009; 316(2):154-64. DOI: 10.1016/j.mce.2009.09.024. View

Salehi M, Ferenczi A, Zumoff B . Obesity and cortisol status. Horm Metab Res. 2005; 37(4):193-7. DOI: 10.1055/s-2005-861374. View

10.

Whorwood C, Donovan S, Flanagan D, Phillips D, Byrne C . Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes. 2002; 51(4):1066-75. DOI: 10.2337/diabetes.51.4.1066. View

11.

. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res. 1998; 6 Suppl 2:51S-209S. View

12.

Chrousos G . The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obes Relat Metab Disord. 2000; 24 Suppl 2:S50-5. DOI: 10.1038/sj.ijo.0801278. View

13.

. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-63. DOI: 10.1016/S0140-6736(03)15268-3. View

14.

Banerji M, Faridi N, Atluri R, Chaiken R, Lebovitz H . Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999; 84(1):137-44. DOI: 10.1210/jcem.84.1.5371. View

15.

Barthel A, Scherbaum W, Bornstein S . [Novel aspects in the mechanisms of steroid diabetes and the regulation of hepatic glucose production by insulin and steroids]. Med Klin (Munich). 2003; 98(5):283-6. DOI: 10.1007/s00063-003-1258-9. View

16.

Meigs J . Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol. 2000; 152(10):908-11; discussion 912. DOI: 10.1093/aje/152.10.908. View

17.

Pedersen S, Jonler M, Richelsen B . Characterization of regional and gender differences in glucocorticoid receptors and lipoprotein lipase activity in human adipose tissue. J Clin Endocrinol Metab. 1994; 78(6):1354-9. DOI: 10.1210/jcem.78.6.8200937. View

18.

Alberti K, Zimmet P, Shaw J . The metabolic syndrome--a new worldwide definition. Lancet. 2005; 366(9491):1059-62. DOI: 10.1016/S0140-6736(05)67402-8. View

19.

Travison T, ODonnell A, Araujo A, Matsumoto A, McKinlay J . Cortisol levels and measures of body composition in middle-aged and older men. Clin Endocrinol (Oxf). 2007; 67(1):71-7. DOI: 10.1111/j.1365-2265.2007.02837.x. View

20.

Stimson R, Andersson J, Andrew R, Redhead D, Karpe F, Hayes P . Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans. Diabetes. 2008; 58(1):46-53. PMC: 2606892. DOI: 10.2337/db08-0969. View